Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M pro inhibitors

被引：0
|
作者：
Peng, Jin-Qi [1 ]
Xiao, Ya-Qi [1 ]
Long, Jiao [1 ]
Zhang, Shuang-Shuang [1 ]
Zhu, Yuan-Yuan [2 ]
Gu, Shuang-Xi [1 ]
机构：
[1] Wuhan Inst Technol, Sch Chem Engn & Pharm, Hubei Key Lab Novel Reactor & Green Chem Technol, Wuhan 430205, Peoples R China
[2] Wuhan Inst Technol, Sch Chem & Environm Engn, Wuhan 430205, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2024年 / 114卷
关键词：
SARS-CoV-2; Main protease; Dithiocarbamates derivatives; Drug design;
D O I：
10.1016/j.bmcl.2024.130011
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
SARS-CoV-2 continues to mutate, spread, and impact public health and daily life. The main protease (Mpro) is essential for the replication and maturation of SARS-CoV-2, making it an ideal target for anti-coronaviral drug discovery and development due to its high conservation and lack of homologous proteases in humans. Herein, we designed and synthesized a series of dithiocarbamate derivatives as potent SARS-CoV-2 M pro inhibitors. Notably, compound L2 exhibited an IC50 value of 9.1 +/- 2.0 nM against SARS-CoV-2 M pro , underscoring its potential as a promising candidate for anti-coronaviral therapy and justifying further research and development.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration
    Zhang, Heng
    Li, Jing
    Toth, Karoly
    Tollefson, Ann E.
    Jing, Lanlan
    Gao, Shenghua
    Liu, Xinyong
    Zhan, Peng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 96
  • [2] Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
    Flury, Philipp
    Breidenbach, Julian
    Krueger, Nadine
    Voget, Rabea
    Schaekel, Laura
    Si, Yaoyao
    Krasniqi, Vesa
    Calistri, Sara
    Olfert, Matthias
    Sylvester, Katharina
    Rocha, Cheila
    Ditzinger, Raphael
    Rasch, Alexander
    Poehlmann, Stefan
    Kronenberger, Thales
    Poso, Antti
    Rox, Katharina
    Laufer, Stefan A.
    Mueller, Christa E.
    Guetschow, Michael
    Pillaiyar, Thanigaimalai
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (02) : 493 - 514
  • [3] Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2
    Hattori, Shin-ichiro
    Bulut, Haydar
    Hayashi, Hironori
    Kishimoto, Naoki
    Takamune, Nobutoki
    Hasegawa, Kazuya
    Furusawa, Yuri
    Yamayoshi, Seiya
    Murayama, Kazutaka
    Tamamura, Hirokazu
    Li, Mi
    Wlodawer, Alexander
    Kawaoka, Yoshihiro
    Misumi, Shogo
    Mitsuya, Hiroaki
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (37)
  • [4] Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors
    Bao, Hong-Lei
    Tu, Gao
    Yue, Qiu
    Liu, Pei
    Zheng, Hui-Li
    Yao, Xiao-Jun
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (04) : 857 - 869
  • [5] Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2
    Yan, Yong
    Liu, Hanwen
    Wu, Di
    Gu, Zhihao
    Guo, Wenhao
    Yao, Hequan
    Lin, Kejiang
    Li, Xuanyi
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (09) : 887 - 903
  • [6] Synthetic Coumarin Derivatives as SARS-CoV-2 Major Protease Inhibitors: Design, Synthesis, Bioevaluation and Molecular Docking
    Mohamed, Nada M.
    Eltelbany, Rania F. A.
    CHEMISTRYSELECT, 2021, 6 (47): : 13616 - 13626
  • [7] Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
    Fassi, Enrico M. A.
    Manenti, Marco
    Citarella, Andrea
    Dei Cas, Michele
    Casati, Sara
    Micale, Nicola
    Schirmeister, Tanja
    Roda, Gabriella
    Silvani, Alessandra
    Grazioso, Giovanni
    MOLECULES, 2023, 28 (05):
  • [8] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
    Katagishi, Daiki
    Yasuda, Daisuke
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    Ohe, Tomoyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
  • [9] New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
    Regnier, Thomas
    Sarma, Diganta
    Hidaka, Koushi
    Bacha, Usman
    Freire, Ernesto
    Hayashi, Yoshio
    Kiso, Yoshiaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2722 - 2727
  • [10] Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors
    Lin, Shengying
    Wang, Xiaoyang
    Tang, Roy Wai-Lun
    Duan, Ran
    Leung, Ka Wing
    Dong, Tina Ting-Xia
    Webb, Sarah E.
    Miller, Andrew L.
    Tsim, Karl Wah-Keung
    MOLECULES, 2024, 29 (11):
12345